![Laurie Fenton Ambrose: About the launch of the INHERIT study](https://oncodaily.com/pub/uploads/2024/05/Screenshot-2024-05-01-163812.png)
Photos of Neal Augenstein and Laurie Fenton Ambrose from LinkedIn
May 3, 2024, 11:44
Laurie Fenton Ambrose: About the launch of the INHERIT study
Neal Augenstein, Reporter at WTOP, shared a post by Laurie Fenton Ambrose, President and CEO of GO2 for Lung Cancer, on X:
“Thank YOU and GO2 for Lung Cancer for all the support and research you provide to people and families living with, and learning about lung cancer.”
Quoting Laurie Fenton Ambrose‘s post:
“Thank you, Neal Augenstein, for talking to me about the launch of the INHERIT study, which is looking into the underlying causes of the inherited risk of lung cancer to inform prevention and treatment. ”
Read further.
Source: Neal Augenstein/X and Laurie Fenton Ambrose/X